Description
While the study demonstrates protective effects of H63D HFE in cellular and animal models, the clinical relevance for human Parkinson’s patients carrying this common variant remains unexplored. This knowledge gap limits translation of findings to precision medicine approaches.
Gap type: open_question Source paper: H63D variant of the homeostatic iron regulator (HFE) gene alters α-synuclein expression, aggregation, and toxicity. (2020, Journal of neurochemistry, PMID:32574378)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:47.728592+00:00”, “resolution_summary”: “Resolved by hypothesis h-e7f5985c: ER Stress Reduction as Adjunctive Therapy to Support Autophagy. Supporting evidence includes debate sess_SDA-2026-04-15-gap-pubmed-20260411-092119-691e1977.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-e7f5985c”, “title”: “ER Stress Reduction as Adjunctive Therapy to Support Autophagy”, “score”: 0.346, “reason”: “20 token overlaps; entity overlap: h63d, hfe”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-092119-691e1977”, “target_gene”: “HFE (H63D variant)”, “target_pathway”: “Iron homeostasis / ferroptosis”, “disease”: “neurodegeneration”, “composite_score”: 0.566, “confidence_score”: 0.68, “status”: “promoted”, “pubmed_evidence_ids”: [“21349849”, “36237618”]}, {“id”: “h-25be864e”, “title”: “H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-Selected ALS Patients”, “score”: 0.342, “reason”: “14 token overlaps; entity overlap: h63d, hfe”, “analysis_id”: “SDA-2026-04-16-gap-ferroptosis-als-d2fb6bf796ed”, “target_gene”: “HFE (H63D variant)”, “target_pathway”: null, “disease”: null, “composite_score”: 0.55, “confidence_score”: 0.55, “status”: “proposed”, “pubmed_evidence_ids”: [“25283820”, “29287521”, “29534603”, “30042732”, “30898788”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-092119-691e1977”, “title”: “The study shows deferiprone rescues wild-type cells but exacerbates toxicity in H63D HFE cells, contradicting the assumption that iron reduction is universally protective in neurodegeneration. This paradox has critical implications for personalized Parkinson’s treatment strategies.\n\nGap type: contradiction\nSource paper: H63D variant of the homeostatic iron regulator (HFE) gene alters α-synuclein expression, aggregation, and toxicity. (2020, Journal of neurochemistry, PMID:32574378)”, “score”: 0.871, “reason”: “20 token overlaps; entity overlap: h63d, hfe, pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-092119-691e1977”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47”, “title”: “While the abstract mentions identifying subcellular roles of protein interactions, the mechanistic principles governing how interaction networks specify subcellular function remain unclear. This knowledge gap limits our ability to predict how disease mutations disrupt cellular compartmentalization in neurons.\n\nGap type: open_question\nSource paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)”, “score”: 0.365, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062222-cc3bcb47”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-17-gap-pubmed-20260410-145520-5692b02e”, “title”: “While RGS6 deficiency causes Parkinson’s-like pathology, whether enhancing RGS6 function or targeting the D2R-Gi/o pathway can reverse or prevent established neurodegeneration remains untested. This is crucial for therapeutic development.\n\nGap type: open_question\nSource paper: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice. (2019, JCI Insight, PMID:31120439)”, “score”: 0.358, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-17-gap-pubmed-20260410-145520-5692b02e”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-pubmed-20260410-145520-5692b02e”, “title”: “While RGS6 deficiency causes Parkinson’s-like pathology, whether enhancing RGS6 function or targeting the D2R-Gi/o pathway can reverse or prevent established neurodegeneration remains untested. This is crucial for therapeutic development.\n\nGap type: open_question\nSource paper: Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice. (2019, JCI Insight, PMID:31120439)”, “score”: 0.358, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-145520-5692b02e”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-110327-26e1d6c7”, “title”: “While the study shows HDAC1/2 deletion improves amyloid clearance and cognition, the specific epigenetic and transcriptional changes that enhance phagocytic function are not mechanistically defined. This knowledge gap limits translation to targeted therapeutic approaches.\n\nGap type: unexplained_observation\nSource paper: Histone Deacetylases 1 and 2 Regulate Microglia Function during Development, Homeostasis, and Neurodegeneration in a Context-Dependent Manner. (2018, Immunity, PMID:29548672)”, “score”: 0.354, “reason”: “9 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-110327-26e1d6c7”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}